Routine Pediatric Vaccinations Lag Amid Pandemic, FDA Approves Steroid-Free Antihistamine Allergy Nasal Spray
Here’s an overview of the latest Drug Topics® coverage.
Don’t waste time searching through articles to find the most current and important news. Drug Topics® have you covered our weekly news roundup of the latest pharmacy-related news you need to know before the weekend kicks in.
Here’s an overview of the latest coverage from Drug Topics®.
Blood-brain barrier crossing antihypertensive drugs linked to less memory loss
Drugs that cross the blood-brain barrier have shown memory benefits in elderly patients, according to a new analysis.
FDA OKs OTC Use Of Steroid-Free Antihistamine Allergy Nasal Spray
The FDA has approved OTC azelastine HCl 0.15% (Astepro Allergy; Bayer).
Routine pediatric vaccinations lagging amid COVID-19 pandemic
There was a marked decline in routine vaccine administration to children and adolescents during the COVID-19 pandemic between March and September 2020; this vaccination coverage lagged behind.
New Data Shows Combination Antibody Treatment Reduces Risk of Death in Hospitalized COVID-19 Patients
The RECOVERY trial showed that antibody combination therapy (REGEN-COV; Regeneron) improved survival in hospitalized patients, a first for anti-COVID-19 antibody treatments.
FDA Approves Oral Blood Thinner For Children
The FDA has approved Pradaxa (dabigatran etexilate) for the treatment of venous thromboembolism in children 3 months to less than 12 years of age.
Read more about Contemporary pediatrics
Half of Latinx, Black Medicare beneficiaries choose Medicare Advantage
Fifty-three percent of Latinx and 49% of Black Medicare beneficiaries choose to enroll in Medicare Advantage; seeing average annual savings of $1,113 and $1,270, respectively, compared to traditional Medicare.
Read more about Managed Healthcare Executive